A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step Desensitization

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-2038
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Comparison of Intravenous Versus Intraperitoneal Administration of Oncolytic Herpes Simplex Virus 1 for Peritoneal Carcinomatosis in Mice

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2008English

Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

A Clinical Trial Investigating Biodistribution and Shedding of an Oncolytic Virus

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Oncolytic and Immunostimulatory Efficacy of a Targeted Oncolytic Poxvirus Expressing Human GM-CSF Following Intravenous Administration in a Rabbit Tumor Model

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2009English

A Clinical Study on Drug-Related Problems Associated With Intravenous Drug Administration

Journal of Basic and Clinical Pharmacy
2014English

Phase I and Pharmacological Study of the New Topoisomerase I Inhibitor GI147211, Using a Daily X 5 Intravenous Administration

British Journal of Cancer
Cancer ResearchOncology
1996English

Development of an Oncolytic Herpes Simplex Virus Using a Tumor-Specific HIF-responsive Promoter

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2010English

Characterization of the Adaptive and Innate Immune Response to Intravenous Oncolytic Reovirus (Dearing Type 3) During a Phase I Clinical Trial

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2008English

Oncolytic Viruses: A Step Into Cancer Immunotherapy

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy